Plain-English translation of NCT06322602 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether placing a small device called an Ommaya reservoir during your brain tumor biopsy can help doctors collect and study fluid from around your brain over time. The fluid contains markers—measurable signs—that could help your doctors understand how your tumor is responding to treatment and which treatments might work best for you. Right now, it's hard for researchers to collect this fluid repeatedly, but this device makes it much easier.
Doctors believe that studying fluid from around the brain could reveal important clues about tumor growth and treatment response, but current methods make it difficult to collect these samples multiple times during treatment. This trial exists to see whether the implanted device can solve that problem and help improve how doctors monitor and treat brain tumors.
You likely qualify if…
You likely don't qualify if…
During your planned brain biopsy, your surgeon will place the small Ommaya reservoir device under your scalp at the same time. After that, you will return for follow-up visits where doctors will collect fluid samples through the device—a simple procedure that does not require a spinal tap. You may also have imaging scans (CT or MRI) as part of the study. The study involves at least two fluid collection visits, and you may have additional optional procedures, but the exact timeline will depend on your treatment plan.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States